Drug Interaction Potential of Osilodrostat (LCI699) Based on Its Effect on the Pharmacokinetics of Probe Drugs of Cytochrome P450 Enzymes in Healthy Adults
Crossref DOI link: https://doi.org/10.1007/s40261-017-0497-0
Published Online: 2017-02-02
Published Print: 2017-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Armani, Sara
Ting, Lillian
Sauter, Nicholas
Darstein, Christelle
Tripathi, Anadya Prakash
Wang, Lai
Zhu, Bing
Gu, Helen
Chun, Dung Yu
Einolf, Heidi J
Kulkarni, Swarupa
Funding for this research was provided by:
Novartis Pharma AG
License valid from 2017-02-02